Imcheck Therapeutics raised €20M in a funding round in May 2017. The company is based in Marseille, France. Investors in the round: Boehringer Ingelheim Venture Fund, GIMV, IDInvest Partners and 2 others. Data as of 21 Sept 2026.
Reported in EUR — no conversion. €20M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
